Mr. Speaker, I am pleased to have the opportunity to speak to Bill S-201, an act to prohibit and prevent genetic discrimination. I would like to thank Senator Cowan for bringing this bill forward and the Senate for giving such thoughtful consideration to this matter both at committee and in its chamber.
Genetic discrimination is an important issue, particularly as more genetic tests become available to Canadians. Senator Cowan has been a champion against genetic discrimination for several years, working with stakeholders in the medical community and driving the public debate on the risks of genetic discrimination in areas like insurance access and workplace practices.
For his work, I know he has received an advocacy award from The American Society of Human Genetics. I also want to thank the hon. member for Don Valley West for sponsoring Bill S-201 here in the House and for his work in bringing this important issue to the attention of both the public and the House.
I also wish to recognize the work of the committee in the other place on Bill S-201. The committee's work exemplifies constructive debate and collaboration by members of different political parties. There is clearly support from across the political spectrum for the objectives of this bill.
As a government, we are committed to ensuring that Canadians have access to the best possible health care, including both preventive and medical treatments. The health of Canadians is of utmost priority for our government. We understand that genetic testing promises great benefits in the fields of health care and medical research.
Genomic-based research has already changed the way health care providers practise medicine. Genetic testing is one of the tools that is revolutionizing the way a diagnosis is made and has helped detect and, in some cases, treat many conditions. In recent years, improvements in technology have dramatically reduced the costs and time required for genetic testing. At the same time, therapies are becoming better tailored to the genetic characteristics of individual patients.
For these reasons, genetic testing is becoming a normal part of medical practice. Some medical experts believe that whole genome sequencing, in which a person's entire genetic makeup is mapped out, perhaps in childhood, will become the new diagnostic norm before long. However, there is increasing evidence that some Canadians are reluctant to undergo genetic testing that doctors believe will help with their health care. They have concerns about how the results of the testing could be used to their disadvantage in the future, most notably in the insurance and employment contexts.
The committee in the other place heard from numerous witnesses who spoke of persons who had been treated in an adverse way because of genetic information revealed about them through genetic testing. The government takes seriously the importance of access to genetic testing in Canada and the need to prevent inappropriate disclosure of genetic test results. The cabinet, therefore, supports the overall objectives of Bill S-201 and, in particular, the bill's proposed amendments to the Canadian Human Rights Act, the CHRA.
These amendments would add genetic characteristics to the list of prohibited grounds of discrimination under the CHRA. They would also specify that, where the ground of discrimination is a refusal to undergo a genetic test or to disclose or authorize the disclosure of the results of a genetic test, the discrimination shall be deemed to be on the ground of genetic characteristics. By adding genetic characteristics as a prohibited ground of discrimination, the CHRA can help to address concerns about the misuse of genetic information in a meaningful way. This is an important step forward.
Anti-discrimination laws, such as the Canadian Human Rights Act, aim to promote equality of opportunity in workplaces and in access to goods and services. They are also aimed at preventing arbitrary disadvantage based on personal characteristics that individuals cannot change about themselves. The CHRA currently prohibits discrimination on 11 grounds, including race, age, sex, and disability.
For those who are concerned about potential discrimination by federal employers based on the results of genetic testing, it is important to note that the CHRA already offers some protection against discrimination based on genetic characteristics. For example, discrimination based on perceived disability due to predisposition to a disease revealed through genetic testing falls within the scope of the existing ground of discrimination based on disability.
Bill S-201 would make existing protections more explicit, as well as expand protection beyond genetic characteristics that would be elated to other prohibited grounds of discrimination, such as disability. This would allow people who were subject to discrimination on the basis of genetic characteristics to make their case in precisely those terms.
Making a formal claim of discrimination can be an intimidating process and one that is often pursued without legal representation. For those who believe they have been discriminated against on the basis of their genetic characteristics, it would now be easier to bring such a claim, since they would no longer have to interpret the law of disability related discrimination or otherwise try to link their claim to another ground in order to establish discriminatory treatment.
Explicit protection for discrimination based on genetic characteristics would also raise awareness of the Canadian Human Rights Act protections and remind federally regulated employers and providers of goods and services of their human rights obligations.
For these reasons, the government supports the CHRA amendments proposed in Bill S-201. The proposed amendment represents an important step forward in creating the framework to address these potential disadvantages toward preventing genetic discrimination in Canada. I look forward to further discussion about the scope and impact of these changes to the CHRA as the bill is considered by a parliamentary committee.
However, it must be recognized that Parliament is limited in its ability to unilaterally address the concerns of stakeholders because there is no federal jurisdiction over private contracts of insurance, nor over employment or services in provincially regulated industries. For this reason, the government will also engage with the provinces and territories with a view to developing effective strategies regarding genetic testing and appropriate protection of the results of this testing.
The minister has informed me that officials in the Department of Justice are already working with officials from other government departments to determine how best to pursue discussions with the provinces and territories about the many different issues arising from the potential uses of genetic information. I know the government would welcome advice and input from Senator Cowan and the hon. member for Don Valley West.
The government looks forward to engaging in discussions that will complement Bill S-201 and can lead to practical and substantive protections for all Canadians.